MORPHEOS INNOVATION

Strategic Consulting for Biotech Commercialization & AI Implementation

APPROACH
SERVICES Business Development AI Productivity & Implementation Scientific Due Diligence Commercialization Analysis
ABOUT LINKEDIN CONTACT

EMPOWERING INNOVATORS

Partnering with founders, investors, and changemakers to build what's next

APPROACH

Distilling Breakthroughs to Reach Investors & Customers: At Morpheos, we help creators, scientists, and engineers build out their vision and communicate the value of their technology to capture their audience's attention and bring them onboard with their vision.

Bridge to Innovation

We work with scientists, engineers, and technical founders to translate complex innovations into functional applications with clear, compelling strategy and clearly defined commercial strategy that resonates with investors, partners, and customers.

The process starts with deep listening — we directly engage with the technical team to understand the depth of the technology and fully grasp and define the technology's unique value proposition. We then work to refine and distill that complexity into a clear and efficient narrative that can (1) unify the development team around common goals, (2) draw in customers, and (3) efficiently capture the attention of investors and potential business partners.

Distillation Process

SERVICES

Business Development & Startup Coaching

+
  • Strategic Collaborations: Identify and facilitate partnerships among biotech, pharma, and academia.
  • Marketing & Pitch Materials: Craft presentations, capability decks, and messaging for investors and collaborators.
  • Negotiations & Contracts: Manage deal structuring, contract terms, and alliance relationships.
  • Networking & Outreach: Leverage conferences and events to build industry connections and generate leads.
  • IP Strategy & Licensing: Drive in-licensing/out-licensing activities, shaping IP portfolios for growth.
  • Technical Sales & Marketing: Oversee client discovery, outreach campaigns, conference sponsorships, and service offerings.

AI Productivity & Implementation

+
  • Workflow Assessment: Analyze current processes to identify where AI tools can streamline daily tasks.
  • Customized Training: Provide one-on-one or team-based coaching on AI-powered applications.
  • Strategic Implementation: Develop tailored action plans for integrating AI solutions into existing workflows.
  • Efficiency & Automation: Recommend best practices and tools to reduce operational overhead.
  • Protoyping & Custom Tool Development: Prototype your ideas and develop custom tools to automate workflows and improve productivity.
  • Ongoing Support: Offer continuous check-ins and updates as new AI solutions emerge.

Scientific Due Diligence & Commercialization Analysis

+
  • Summarize Key Scientific Concepts: Provide concise, high-level reviews of preclinical and clinical data.
  • Commercialization Feasibility: Assess market potential, competitive landscapes, and regulatory paths.
  • Preclinical Evaluation: Review and critique in vitro and in vivo data, highlighting strengths and weaknesses.
  • Path-to-Clinic Strategy: Outline critical steps for clinical development and de-risking.
  • Target Validation & Study Design: Develop comprehensive roadmaps for proof-of-concept and efficacy trials.
  • KOL Engagement: Identify key opinion leaders, gather expert feedback, and integrate insights into development plans.

ABOUT

Brandon Hogstad, Ph.D., is principal consultant and founder of Morpheos Innovation LLC, where he partners with startups, investors, and academic institutions across biotech and AI-driven platforms. He specializes in strategic commercialization, alliance management, and scientific due diligence—guiding breakthrough innovations from concept to market.

Before launching Morpheos, Brandon led drug discovery accelerator programs and high-impact collaborations at NYU Langone Health, securing partnerships with global industry leaders like Sanofi and Pfizer (including the antiviral research that contributed to Paxlovid). He later advanced AI-driven immunotherapy initiatives at Immunai, forging strategic relationships to harness single-cell genomics for precision medicine.

Brandon earned his Ph.D. in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai. His contributions have appeared in top-tier journals such as Nature and the Journal of Experimental Medicine. Drawing on his broad expertise in target validation, preclinical strategy, and cutting-edge AI applications, Brandon remains committed to advancing medical science and global health through technology-driven innovation.